| 國立成功大學 |
2022 |
Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy
|
Liu, P.-Y.;Su, C.-H.;Kuo, F.-Y.;Lee, W.-L.;Wang, Y.-C.;Lin, W.-S.;Chu, P.-H.;Lu, T.-M.;Lo, P.-H.;Lee, C.-H.;Lan, W.-R.;Huang, C.-L.;Tsukiyama, S.;Yang, W.-C.;Cheng, L.-C.;Rafael, V.;Nikolajsen, C.;Yin, W.-H. |
| 國立成功大學 |
2022 |
A HANC Risk Stratification Score for Antiplatelet Therapy Optimization with Low-Dose Prasugrel in Taiwanese Acute Coronary Syndrome Patients from the Switch Study
|
Lee, W.-L.;Wang, Y.-C.;Su, C.-S.;Lee, H.-F.;Tung, Y.-C.;Liu, P.-Y.;Su, C.-H.;Kuo, F.-Y.;Lin, W.-S.;Chu, P.-H.;Lu, T.-M.;Lo, P.-H.;Tsukiyama, S.;Yang, W.-C.;Cheng, L.-C.;Yin, W.-H.;Lin, Y.-H. |
| 國立成功大學 |
2022 |
The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
|
Hsuan, C.-F.;Lin, F.-J.;Lee, T.-L.;Yang, K.-C.;Tseng, W.-K.;Wu, Y.-W.;Yin, W.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.;Chang, W.-T.;Lee, Y.-H.;Chen, J.-W.;Sheu, H.-H.;Hsieh, I.-C.;Chen, Y.-S.;Liu, M.-E.;Chen, Chen C.-H.;Lin, Lin L.-Y.;Yeh, H.-I.;Sung, Sung S.-H.;Liu, P.-Y.;Wu, I.-H.;Wang, Z.-H.;Chiu, K.-M.;Kuo, C.-T.;Wang, T.-D.;Hung, C.-L.;Wang, C.-H.;Wang, C.-C.;Wang, C.-Y.;Jeng, Jeng J.-S.;Lin, T.-H.;Kao, H.-L.;Chu, P.-H.;Lin, F.-J.;Chen, Z.-C.;Chang, K.-C.;Yin, W.-H.;Tseng, W.-K.;Investigators, The Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry |
| 國立成功大學 |
2022 |
The Efficacy and Safety of Short-Term Tolvaptan Usage in Patients with Acute Decompensated Heart Failure
|
Lin, Y.-H.;Tsai, C.-H.;Chiang, Chiang C.-E.;Kuo, J.-Y.;Yin, W.-H.;Wen, M.-S.;Lo, P.-H.;Liu, P.-Y.;Lin, T.-H.;Chen, Z.-C.;Shyu, K.-G.;Hung, M.-J.;Hwang, J.-J.;Tseng, C.-D. |
| 臺大學術典藏 |
2021-12-22T03:54:12Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
JIANN-SHING JENG; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; Wu C.-C.; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-11-23T06:18:00Z |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
CHIEN-BOON JONG; Li H.-Y.; Pan S.-L.; Hsieh M.-Y.; Su F.-Y.; Chen K.-C.; Yin W.-H.; Chan S.-H.; Wu Y.-W.; Wang K.-Y.; Chang K.-C.; Hwang J.-J.; Wu C.-C. |
| 臺大學術典藏 |
2021-08-31T06:43:37Z |
Rationale and design of the ADAPT-TAVR trial: A randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement
|
Park H.; Kang D.-Y.; Ahn J.-M.; Kim K.W.; Wong A.Y.T.; Lam S.C.C.; Yin W.-H.; Wei J.; Lee Y.-T.; Kao H.-L.; Lin M.-S.; Tsung-Yu Ko; Kim W.-J.; Kang S.H.; Ko E.; Kim D.-H.; Koo H.J.; Yang D.H.; Kang J.-W.; Jung S.C.; Lee J.-H.; Yun S.-C.; Park S.-J.; Park D.-W. |
| 臺大學術典藏 |
2021-08-31T05:27:00Z |
The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15 years in a Taiwanese population
|
Yin W.-H.; Lu T.-H.; Chen K.-C.; Cheng C.-F.; Lee J.-C.; Liang F.-W.; Huang Y.-T.; LI-TAN YANG |
| 臺大學術典藏 |
2021-08-31T05:27:00Z |
Characteristics of early and late adopting hospitals providing percutaneous coronary intervention in Taiwan
|
Lu T.-H.; Huang Y.-T.; Lee J.-C.; LI-TAN YANG; Liang F.-W.; Yin W.-H.; Kawachi I. |
| 臺大學術典藏 |
2021-08-24T06:21:20Z |
Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian Population
|
Yoon S.-H.; Ahn J.-M.; Hayashida K.; Watanabe Y.; Shirai S.; Kao H.-L.; Yin W.-H.; Lee M.K.-Y.; Tay E.; Araki M.; Yamanaka F.; Arai T.; MAO-SHIN LIN; Park J.-B.; Park D.-W.; Kang S.-J.; Lee S.-W.; Kim Y.-H.; Lee C.W.; Park S.-W.; Muramatsu T.; Hanyu M.; Kozuma K.; Kim H.-S.; Saito S.; Park S.-J.; Asian TAVR Investigators |
| 臺大學術典藏 |
2021-08-24T06:21:14Z |
Rationale and design of the ADAPT-TAVR trial: A randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement
|
Park H.; Kang D.-Y.; Ahn J.-M.; Kim K.W.; Wong A.Y.T.; Lam S.C.C.; Yin W.-H.; Wei J.; Lee Y.-T.; Kao H.-L.; MAO-SHIN LIN; Ko T.-Y.; Kim W.-J.; Kang S.H.; Ko E.; Kim D.-H.; Koo H.J.; Yang D.H.; Kang J.-W.; Jung S.C.; Lee J.-H.; Yun S.-C.; Park S.-J.; Park D.-W. |
| 臺大學術典藏 |
2021-08-24T06:21:14Z |
Transcatheter aortic valve implantation during the COVID-19 pandemic: Clinical expert opinion and consensus statement for Asia
|
Tay E.L.; Hayashida K.; Chen M.; Yin W.-H.; Park D.-W.; Seth A.; Kao H.-L.; MAO-SHIN LIN; Ho K.-W.; Buddhari W.; Chandavimol M.; Posas F.-E.; Nguyen Q.N.; Kong W.; Rosli M.A.; Hon J.; Firman D.; Lee M. |
| 臺大學術典藏 |
2021-08-24T06:21:13Z |
Sex differences in patients undergoing transcatheter aortic valve replacement in Asia
|
Chiam P.T.L.; Hayashida K.; Watanabe Y.; Yin W.-H.; Kao H.-L.; Lee M.K.Y.; Posas F.E.; Chandavimol M.; Buddhari W.; Dy T.C.; Nguyen N.Q.; Kim W.J.; Chang K.; MAO-SHIN LIN; Lam Y.-Y.; Pham H.M.; Yahaya S.A.; Ho K.W.; Pan W.; Liu X.-B.; Wang J.; Kim H.S.; Chen M. |
| 臺大學術典藏 |
2021-07-06T02:37:31Z |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li Y.-H.; Tseng W.-K.; Yin W.-H.; FANG-JU LIN; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Sheu W.H.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-07-02T02:35:17Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang C.-E.; Lin S.-Y.; Lin T.-H.; Wang T.-D.; Yeh H.-I.; Chen J.-F.; Tsai C.-T.; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chao T.-H.; Shyu K.-G.; WEI-SHIUNG YANG; Ueng K.-C.; Chu P.-H.; Yin W.-H.; Wu Y.-W.; Cheng H.-M.; Shin S.-J.; Huang C.-N.; Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L. |
| 臺大學術典藏 |
2021-05-24T03:41:54Z |
2014 guidelines of taiwan society of cardiology (TSOC) for the management of pulmonary arterial hypertension
|
Hsu C.-H.; Ho W.-J.; Huang W.-C.; Chiu Y.-W.; Hsu T.-S.; Kuo P.-H.; HSAO-HSUN HSU; Chang J.-K.; Cheng C.-C.; Lai C.-L.; Liang K.-W.; Lin S.-L.; Sung S.-H.; Tsai W.-C.; Weng K.-P.; Hsieh K.-S.; Yin W.-H.; Lin S.-J.; Wang K.-Y. |
| 臺大學術典藏 |
2021-05-06T02:57:42Z |
2019 focused update of the guidelines of the Taiwan society of cardiology for the diagnosis and treatment of heart failure
|
Wang C.-C.;Wu C.-K.;Tsai M.-L.;Lee C.-M.;Huang W.-C.;Chou H.-H.;Huang J.-L.;Nai-Hsin Chi;Yen H.-W.;Tzeng B.-H.;Chang W.-T.;Chang H.-Y.;Wang C.-H.;Lu Y.-Y.;Tsai J.-P.;Su C.-H.;Cherng W.-J.;Yin W.-H.;Tsai C.-T.;Wu Y.-W.;Lin J.-L.;Hwang J.-J.; Wang C.-C.; Wu C.-K.; Tsai M.-L.; Lee C.-M.; Huang W.-C.; Chou H.-H.; Huang J.-L.; NAI-HSIN CHI; Yen H.-W.; Tzeng B.-H.; Chang W.-T.; Chang H.-Y.; Wang C.-H.; Lu Y.-Y.; Tsai J.-P.; Su C.-H.; Cherng W.-J.; Yin W.-H.; Tsai C.-T.; Wu Y.-W.; Lin J.-L.; Hwang J.-J. |
| 臺大學術典藏 |
2021-03-18T08:54:28Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; YEN-WEN WU; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:23Z |
TSOC-HFrEF registry: A registry of hospitalized patients with decompensated systolic heart failure: Description of population and management
|
Wang C.-C.; Chang H.-Y.; Yin W.-H.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J. |
| 臺大學術典藏 |
2021-03-18T08:54:21Z |
The Obesity-Mortality Paradox in Patients With Heart Failure in Taiwan and a Collaborative Meta-Analysis for East Asian Patients
|
Lin G.-M.; Li Y.-H.; Yin W.-H.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Wang C.-C.; Yeh S.-J.; Lin W.-S.; Chan K.-C.; Chang H.-C.; Chang K.-C.; Chen Z.-C.; Chen S.-M.; Chu P.-H.; Hsu C.-H.; Huang J.-L.; Kuo J.Y.; Lin J.-L.; Lin W.-S.; Mar G.-Y.; Shyu K.-G.; Sung S.-H.; Tseng W.-K.; Voon W.-C.; Wang J.-H.; Wen M.-S.; Yang N.-I. |
| 臺大學術典藏 |
2021-03-18T08:54:19Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:18Z |
One-year outcomes of acute decompensated systolic heart failure in Taiwan: Lessons from TSOC-HFreF registry
|
Chang H.-Y.; Wang C.-C.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.; Yin W.-H. |
| 臺大學術典藏 |
2021-03-18T08:54:17Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
